AC710 is a potent, orally active, and selective platelet-derived growth factor receptor-family kinase inhibitor with potential anticancer activity. Its IC50 values are 1.2, 2, 7.7 and 10.5 nM for KIT, FLT3, PDGFRβ and CSF1R respectively; Kd = 1.3 nM for PDGFRα.. AC710 causes tumor regression of leukemia cell xenografts in mice. AC710 also reduces joint swelling and inflammation in a mouse model of collagen-induced arthritis. AC710 is now a preclinical development candidate.
MedKoo Cat#: 406202
Name: AC710
CAS#: 1351522-04-7 (free base)
Chemical Formula: C31H42N6O4
Exact Mass: 562.3268
Molecular Weight: 562.70
Elemental Analysis: C, 66.17; H, 7.52; N, 14.94; O, 11.37
| Solvent | mg/mL | mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 13.0 | 23.10 |
The following data is based on the product molecular weight 562.70 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
